桑古纳林通过抑制CD97抑制,抑制了牛类类型3型偏流感病毒的复制
Huasong Chang1, Ran Kang1, Rukun Yang1
1Ruminant Diseases Research Center, Key Laboratory of Animal Resistant Biology of Shandong, College of Life Sciences, Shandong Normal University, Jinan, Shandong 250014, China.
Veterinary microbiology
|October 24, 2025
概括
桑圭纳林通过促进分化群97 (CD97) 蛋白质的降解,有效地抑制了牛甲型流感病毒3型 (BPIV3) 复制,这表明它对牛呼吸系统疾病的治疗潜力.
科学领域:
- 兽医病毒学 兽医病毒学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 牛甲型流感病毒3型 (BPIV3) 导致牛的严重呼吸道疾病.
- 目前,对于BPIV3感染,没有有效的抗病毒治疗方法.
- 分化集群97 (CD97) 是已知的RNA病毒复制的调节者.
研究的目的:
- 为了研究血红素对BPIV3的抗病毒作用.
- 阐明血红素作用的潜在分子机制.
- 评估血红素作为BPIV的潜在治疗剂3.
主要方法:
- 剂量和时间依赖的测试来评估血红素的BPIV3复制抑制.
- CD97的淘汰实验证实其在血红素疗效中的作用.
- 在血治疗后对CD97mRNA和蛋白质水平的分析.
- 使用特定抑制剂 (Bafilomycin A1,Z-VAD-FMK) 对血红素对自和亡途径的影响的研究.
主要成果:
- 桑圭纳林以剂量和时间依赖的方式显著抑制了BPIV3复制.
- 血红素的抗病毒作用取决于CD97的表达.
- 桑古纳林通过自 (NBR1) 和亡 (caspases-3/8) 促进了CD97蛋白质的降解.
- 桑古纳林增强了自和亡过程.
结论:
- 桑古纳林对BPIV3具有强大的抗病毒活性.
- 该机制涉及CD97蛋白质降解,增强的自和亡.
- 桑古纳林作为牛群BPIV3感染的新疗法候选人显示出前景.
相关概念视频
Influenza
101
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
101
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73


